Simnikiwe Hlatshaneni
Premium Journalist
4 minute read
18 Apr 2021
6:22 pm

Johnson & Johnson halt could bolster third wave

Simnikiwe Hlatshaneni

Nehawu continues its support of the halting of the Sisonke Program through which the healthcare workers were being vaccinated.

Healthcare workers administer the first batch of Johnson & Johnson vaccines at Chris Hani Baragwanath Hospital in Soweto on 17 February 2021. Picture: Michel Bega

  South Africans' chances against the imminent third wave of Covid-19 infections may be worse off because of the halting of the Johnson & Johnson vaccine Janssen, says one of the doctors involved in trialling the drug. Dr Hugo Tempelman, CEO of the Ndlovu Care Group which conducted trials for the vaccine last year, says though it's understandable why first world countries can afford to halt the rollout of the vaccine, the same couldn't be said about South Africa and other developing nations. Weighing the risks of adverse effects from the vaccine against those faced by South Africa, should it...